Stem cell shot aims to tame MS in Drug-Resistant patients
NCT ID NCT04956744
First seen Apr 08, 2026 · Last updated May 07, 2026 · Updated 6 times
Summary
This early-stage study tests a single dose of IMS001, a stem cell therapy made from human embryonic cells, in 30 adults with multiple sclerosis (MS) who did not get better with standard treatments. The main goal is to check if the treatment is safe and tolerable. Researchers will also look for early signs that it might help control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rocky Mountain MS Clinic
Salt Lake City, Utah, 84103, United States
-
Shepherd Center
Atlanta, Georgia, 30309, United States
-
UMass Memorial Medical Center
Worcester, Massachusetts, 01605, United States
Conditions
Explore the condition pages connected to this study.